U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06805864) titled 'Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma' on Jan. 28.
Brief Summary: The goal of this clinical trial is to learn if pembrolizumab works for cervical adenocarcinoma treat with concurrent chemo-carbon-ion radiaotherapy (CIRT).
The main questions it aims to answer are:
* Does concurrent chemo-CIRT with pembrolizumab improves 2-year progression-free survival (PFS), compared with concurrent chemoradiotherapy with conventional X-rays?
Study Start Date: Feb. 01
Study Type: INTERVENTIONAL
Condition:
Cervical Adenocarcinoma
Cervical Adenosquamous Carcinoma
Interven...